2019 ISHLT ( International Society of Heart Lung Transplantation ) 39Th Annual Meeting & Scientific Sessions

– 05 RESEARCH SESSION 03 Chronic Lung Allograft Dysfunction Anything New

– 06 RESEARCH SESSION 04 So Wrong It_s Right The Right Ventricle and MCS

– 07 RESEARCH SESSION 06 Pediatric Donor Utilization, MCS, Readmissions and More

– 08 SYMPOSIUM SESSION 07 Making Co-Morbidities Great Again Practical Updates in Co-Morbidity Management

– 09 RESEARCH SESSION 08 ISHLT Spotlight Heart Transplantation in Latin America

– 10 SYMPOSIUM SESSION 09 Re-Focusing the Blurry Vision Biomarkers of Thoracic Allograft Rejection

– 11 RESEARCH SESSION 10 Heart Donor Management and Allocation Setting It Up For Success

– 12 RESEARCH SESSION 11 Chronic Lung Allograft Dysfunction Overcoming the Hurdle

– 13 RESEARCH SESSION 12 When Short-Term Becomes Long-Term Transition from Temporary to Permanent Mechanical Support

– 14 SYMPOSIUM SESSION 13 They Tell Me I Am Irregular Why Do They Care Arrhythmias in LVAD Recipients

– 15 SYMPOSIUM SESSION 14 Part of (Their) World Discharging Patients Home with a New Device

– 16 RESEARCH SESSION 15 Pharmacotherapy in Transplantation Reading the Tea Leaves to Improve Outcomes

– 17 RESEARCH SESSION 16 Junior Faculty and Trainees Clinical Case Dilemmas The Best of the Best

– 18 RESEARCH SESSION 17 Tolerance Is All We Need in Thoracic Transplantation

– 19 RESEARCH SESSION 18 Ex-Vivo Heart Perfusion and Preservation Some Like It Hot – or Not!

– 20 SYMPOSIUM SESSION 19 Chronic Lung Allograft Dysfunction (CLAD) The End of the Beginning

– 21 RESEARCH SESSION 20 The Beat Goes On Arrhythmias and Pacing During MCS

– 22 SYMPOSIUM SESSION 21 Short Term Mechanical Support Taking the Next Leap Forward

– 23 SYMPOSIUM SESSION 22 What Do We Do Burning Platforms in Pediatric Thoracic Transplant

– 24 SUNRISE SYMPOSIUM 01 In the Thick of It Hypertrophic and Amyloid Cardiomyopathies

– 25 SUNRISE SYMPOSIUM 02 Immunobiology of the Older Lung Transplant Recipient

– 26 SUNRISE SYMPOSIUM 03 From Isolated to Mainstream Evolving ECMO Strategies That Are Reshaping Outcomes

– 27 SUNRISE SYMPOSIUM 04 Nobody is CLAD to See AMR in Lung Transplantation

– 28 SUNRISE SYMPOSIUM 05 I Want to Ride My Bicycle Cardiopulmonary Exercise Testing (CPET) for PAH and CTEPH

– 29 SUNRISE SYMPOSIUM 06 Making Deals with the Devil Substances of Abuse from Pre- to Post-Transplant

– 30 SYMPOSIUM SESSION 27 Medical Management of LVAD Patients Once the Chest is Closed, the Trouble Begins

– 31 RESEARCH SESSION 24 Molecular Diagnostics in Heart Transplantation It_s All in the Genes

– 32 RESEARCH SESSION 29 Pediatric Lung Transplantation Are We Moving Forward

– 33 RESEARCH SESSION 23 Hepatitis C+ Cardiac Donors Do They Get an A+

– 34 SYMPOSIUM SESSION 25 The Magic Kingdom of the Bronchoscopy Pathogens with Real Implications and Those to Disregard

– 35 RESEARCH SESSION 26 Mechanical Lung Support for Isolated Organs and Patients

– 36 RESEARCH SESSION 28 Tissue is Not the Only Issue Advances in Thoracic Transplant Pathology

– 37 RESEARCH SESSION 31 Slaying the Dragon Hepatitis C and Thoracic Transplantation

– 38 RESEARCH SESSION 30 Get Up and Go! Predicting Survival in Heart Failure

– 39 SYMPOSIUM SESSION 32 Ex-Vivo Lung Perfusion (EVLP) in 2019 From Research to Implementation

– 40 RESEARCH SESSION 33 Brain Attack Strokes and MCS

– 41 RESEARCH SESSION 34 Never Mind the Leaks Addressing Valvular Disease with LVADs

– 42 SYMPOSIUM SESSION 35 Bring Out Your Dead The Postmortem Evaluation in the Thoracic Transplant Setting

– 43 SYMPOSIUM SESSION 36 Learning from the Children Important Lessons from the Pediatric and Congenital Heart Disease VAD Experience

– 44 SYMPOSIUM SESSION 37 JHLT at ISHLT The Year in a Capsule

– 45 RESEARCH SESSION 38 Early Career Scientist Award Candidate Presentations

– 46 RESEARCH SESSION 39 Walking a Tightrope The Double-Edged Sword of Drugs after Heart Transplant

– 47 RESEARCH SESSION 41 Perfecting the Graft LVAD Pump Management, Outcomes and Medications

– 48 RESEARCH SESSION 42 Too Much or Two Little Obesity and Frailty in MCS

– 49 SYMPOSIUM SESSION 43 Changes in the World of Pulmonary Hypertension Nice or Not Nice

– 50 RESEARCH SESSION 44 Philip K. Caves Award Candidate Presentations

– 51 SYMPOSIUM SESSION 48 Advances in Short- and Long-Term Mechanical Circulatory Support – What’s Next

– 52 RESEARCH SESSION 45 Acute Cardiac Rejection New Approaches to an Old Problem

– 53 SYMPOSIUM SESSION 46 FUN and Games with FUNgal Infections in Lung Transplantation

– 54 RESEARCH SESSION 47 Back to the Basics Physiological Alterations During Continuous Flow VAD Support

– 55 RESEARCH SESSION 49 The Personal Connection Psychological Issues and Care for Donor Families, Patients and Providers

– 56 RESEARCH SESSION 50 Pulmonary Hypertension in Translation From Novel Biomarkers to Cutting Edge Clinical Results

– 57 SUNRISE SYMPOSIUM 07 Highways to Hell Chronic Lung Allograft Dysfunction

– 58 SUNRISE SYMPOSIUM 08 Print, Replace or Innovate Alternative Strategies to Cardiac Transplantation

– 59 SUNRISE SYMPOSIUM 09 MCS Infections New Twists in an Old Saga

– 60 SUNRISE SYMPOSIUM 10 Cardiac Reverse Remodeling in MCS State of the Art

– 61 SUNRISE SYMPOSIUM 11 The Mission IS Possible If You Choose to Accept it The Processes of Performing Research

– 62 SUNRISE SYMPOSIUM 12 A Bloody Mess Management of Hematologic Complications in Transplantation and MCS

– 63 PLENARY SESSION FRIDAY

– 64 JOINT ISHLTIPTA SYMPOSIUM SESSION 56 EBV and CMV are Not as Easy as 1-2-3 When Caring for Pediatric Thoracic Transplant Recipients

– 65 RESEARCH SESSION 51 Cardiac Allograft Vasculopathy A Never-ending Story

– 66 JOINT ISHLTSCMR SYMPOSIUM SESSION 52 Cardiac MRI and the World of Heart Failure When Two Disciplines Harmonize

– 67 RESEARCH SESSION 53 Chasing the Golden Snitch Optimizing Outcomes of MCS Infections

– 68 RESEARCH SESSION 54 Swipe Right or Swipe Left Matching Donors and Recipients in Lung Transplantation

– 69 RESEARCH SESSION 55 Score Now – Or Forever Hold Your Peace Prediction and Risk in MCS

– 70 SYMPOSIUM SESSION 57 Take These Broken Lungs and Learn to Fly Great Debates for Patients with PAH Awaiting Transplant

– 71 SYMPOSIUM SESSION 58 Resilience in the Face of Calamity The Art of Preventing PTE Disasters

– 72 RESEARCH SESSION 59 Heart Transplant Short-Term Outcomes Getting it Right From the Start

– 73 JOINT ISHLTABTO SYMPOSIUM SESSION 60 Combining Experiences to Enhance Thoracic Organ Transplantation Worldwide

– 74 SYMPOSIUM SESSION 61 Making Them Count Enhancing Lung Donor Utilization

– 75 RESEARCH SESSION 62 Under New Management Novel Strategies for MCS

– 76 JOINT ISHLTICCAC SYMPOSIUM SESSION 63 Faster, Higher, Stronger Monitoring Exercise in Cyberspace

– 77 RESEARCH SESSION 64 Highlights of Challenging Topics in Pediatric Heart Transplant and MCS

– 78 SYMPOSIUM SESSION 65 All Talk, No Action New Strategies and Best Practices to Maximize Donor Heart Utilization

– 79 RESEARCH SESSION 66 Between the Devil and the Deep Blue Sea Fungus or CMV

– 80 RESEARCH SESSION 67 Diagnostics and Immunosuppression in Lung Transplantation

– 81 RESEARCH SESSION 68 LV Recovery after MCS From Promise to Reality

– 82 RESEARCH SESSION 69 Tricks of the Trade Management Considerations with Continuous Flow LVADs

– 83 SYMPOSIUM SESSION 70 Matters of Life and Death Palliative and End of Life Care in Transplant Medicine

– 84 SYMPOSIUM SESSION 71 Breaking Bad The Right Ventricle and Exercise Hemodynamics Rediscovered

– 85 SUNRISE SYMPOSIUM 18 So Your Patient is on ECMO … Now What Considerations for Drug Dosing and Anticoagulation in ECMO

– 86 SUNRISE SYMPOSIUM 17 A Brand-New Day The New Normal in Pediatric Thoracic Transplantation

– 87 NRISE SYMPOSIUM 16 Fragility Not Necessarily Failure

– 88 SUNRISE SYMPOSIUM 15 Lung Transplant Candidate Selection Challenging Cases

– 89 SUNRISE SYMPOSIUM 13 A Fork in the Road How Can We Compare Interventional Therapies in CTEPH

– 90 SUNRISE SYMPOSIUM 14 One Size Does Not Fit All Personalized Medicine in Heart Transplantation

– 91 PLENARY SESSION SATURDAY

– 92 RESEARCH SESSION 77 Thicker than Water Bleeding and LVADs

– 93 SYMPOSIUM SESSION 76 Location, Location, and Allocation Worldwide Application of Broader Sharing in Lung Transplant

– 94 SYMPOSIUM SESSION 75 Cardiac Allograft Vasculopathy Have Hope, Ye Who Enter

– 95 RESEARCH SESSION 74 Frontiers of Cost-Efficacy and Policy in Transplant and MCS

– 96 RESEARCH SESSION 73 Life on the Cutting Edge CTEPH and Surgical Management of PH

– 97 SYMPOSIUM SESSION 72 Seeing the Light Antibodies in Thoracic Transplantation

– 98 RESEARCH SESSION 80 Heart Transplant Long-Term Outcomes In It for the Long Haul

– 99 RESEARCH SESSION 79 Go with the Flow Hemodynamic Guiding Therapies in Heart Failure

– 100 RESEARCH SESSION 78 The Beginning of the End in Lung Transplantation PGD, AMR and CLAD

– 101 RESEARCH SESSION 83 What_s Holding Me Back Exercise in LVAD Patients

– 102 RESEARCH SESSION 82 Donor Lung Management Can We Do Better

– 103 RESEARCH SESSION 81 Primary Graft Dysfunction and Acute Lung Rejection

– 104 Q&A

104 Videos

Date of Release : April 3-6 2019